SAILIFE · NSE
Not in active coverage. Cited reporting has mentioned Sai Life Sciences, the record of those mentions is below. Your interest is logged; coverage expands by demand.
Sai Life Sciences Chief Financial Officer Sivaramakrishnan Chittor stated that the company continues to observe consistent advancement in the China Plus One strategy as major pharmaceutical corporations are diversifying their supply chains.
Sai Life Sciences is expanding capacity and moving into peptides and formulations as global pharma companies diversify supply chains beyond China.
Sai Life Sciences Ltd is quoting at Rs 1617, up 1.03% on the day as on 12:49 IST on the NSE.
Sai Life Sciences' shares gained 5% on Tuesday, September 8, to hit an intraday and fresh record high of ₹1,657.20 apiece.
This page lists where cited reporting has mentioned Sai Life Sciences. It is not the full dossier: developments here are single mentions, not corroborated records. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.